Aripiprazole augmentation in poor insight obsessive-compulsive disorder: a case report

Aripiprazole augmentation in poor insight obsessive-compulsive disorder: a case report

Blog Article

Abstract Background Obsessive-compulsive disorder is associated with a relevant impairment in social leather baton holder and interpersonal functioning and severe disability.This seems to be particularly true for the poor insight subtype, characterised by a lack of consciousness of illness and, consequently, compliance with treatment.Poor responsiveness to serotonergic drugs in poor insight obsessive-compulsive patients may also require an augmentation therapy with atypical antipsychotics.Methods We reviewed a case in which a patient with a long history of poor insight obsessive-compulsive disorder was treated with a high dosage of serotonin reuptake inhibitors.Results The treatment resulted in a poor outcome.

This patient was therefore augmentated with aripiprazole.Conclusion Doctors should consider aripiprazole as a possible augmentation strategy for serotonergic poor responder obsessive-compulsive tablet at ackermans patients, but further research on these subjects is needed.